AGAnabele Stefânia Gomes

Anabele Stefânia Gomes

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Anabele Stefânia Gomes has a total of 25 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Allelopathic hypotheses revisited: the interactions between native and exotic species in the Brazilian savanna

    by Cristiele DOS Santos Souza, Gabriel Marins, Isabela Fernanda L.G. Camargo, Larissa Boaz DE Lima, Anabele Stefânia Gomes, Fabian Borghetti

    We investigated allelopathic interactions between native and exotic species of the Cerrado biome. We studied the effects of the exotic Andropogon gayanus and the native A. bicornis on the initial growth of two native (A. fastigiatus and Lepidaploa aurea) and two exotic species (Melinis minutiflora and Stapfochloa elata). Leaves or roots of the donors were each mixed at ratios of 0.75, 1.5 and 3% (litter/soil) with soil samples collected in the same areas where they spontaneously co-occur with their target species. We found that A. gayanus inhibited the growth of all target species, what agrees with the novel weapon hypothesis. The native A. bicornis stimulated the growth of the two native species and of S. elata but inhibited the growth of the exotic M. minutiflora, in line with the homeland security hypothesis. Our studies suggest that allelopathy may have a part in the invasiveness of A. gayanus and that the inhibitory effect of A. bicornis on the growth of M. minutiflora might help to control the spread of this exotic grass. We conclude that allelopathy may be involved in the interactions between species and be used in controlling the spread of exotic species over many areas of the Cerrado.


  • Open Access

    Avaliação do potencial alelopático e fitotoxicidade de Hymenaea stigonocarpa em espécies invasoras e cultivadas

    by Sophia Motta Grossi, Natália Mendes Gomes Magalhães, Sarah C. Caldas Oliveira, Anabele Stefânia Gomes, Fabian Borghetti

    O Cerrado é um hotspot mundial de biodiversidade e vem sofrendo com a expansão das áreas destinadas produção de commodities. Mais da metade de sua área foi desmatada ou transformada por ação antrópica, incluindo a introdução e/ou expansão de plantas oportunistas. Atualmente, inúmeras espécies se tornaram invasoras de ambientes naturais do bioma. Buscando mitigar este processo invasivo, a utilização de espécies nativas que inibam o desenvolvimento das plantas invasoras e ao mesmo tempo favoreçam a biodiversidade nativa representa uma estratégia promissora. Dessa forma, este estudo avaliou o potencial alelopático da rizosfera de plântulas de Hymenaea stigonocarpa (jatobá-do-cerrado) na germinação e crescimento inicial das espécies invasoras, Megathyrsus maximus e Ipomoea triloba, e da cultivada, Sesamum indicum, plantadas em solo previamente ocupado por plântulas de jatobá-do-cerrado. Ademais, avaliou-se o efeito fitotóxico do extrato aquoso de suas raí­zes em coleóptilos de Triticum aestivum, usando o percentual de inibição do seu crescimento. As espécies alvo plantadas em solo previamente ocupado por plântulas de jatobá-do-cerrado apresentaram inibição significativa do crescimento em comparação ao controle. A inibição do crescimento de S. indicum foi de 31% da parte aérea e de 48% da radicular; enquanto M. maximum teve inibição de 41 e 84%, respectivamente. Já I. triloba não germinou. Contudo, não se observou alteração significativa do alongamento dos coleóptilos de T. aestivum expostos ao extrato de jatobá-do-cerrado. Os resultados obtidos sugerem potencial atividade alelopática desta nativa sobre plantas daninhas, indicando seu uso como estratégia em processos de recuperação de áreas degradadas do Cerrado com o benefí­cio de controlar o desenvolvimento de invasoras.


  • Open Access

    Efeitos do Tegumento e teor de água de sementes de Plathymenia reticulata e Stryphnodendron adstringens na tolerância a choques térmicos

    by Cristiele dos Santos Souza, Maiky Lopes Paulo, José de Oliveira Cruz, Tayara Colins Nunes, Stêfani Karoline Melo Carvalho, Eloisa Do Vale Nogueira, Ana Carolina Tavora Lima Alves, Anabele Stefânia Gomes, Fabian Borghetti

    RESUMO O tegumento e conteúdo de água das sementes podem interferir na sua tolerância a choques térmicos, assim como o seu ambiente de origem. Para testar essas possibilidades, sementes de Plathymenia reticulata e Stryphnodendron adstringens foram coletadas no norte do Estado de Minas Gerais (representando savana seca) e no nordeste do Estado do Mato Grosso (representando savana úmida) do bioma Cerrado, e suas respostas a choques térmicos de 110, 140 e 170 ºC por 2,5 minutos foram avaliadas sob diferentes condições; intactas, escarificadas, e embebidas após escarificação. Sementes escarificadas e embebidas germinaram mais rapidamente para ambas as espécies. Sementes de savana seca apresentaram menor teor de água inicial e germinação mais lenta para ambas as espécies, porém maior tolerância a choques térmicos que sementes de savana úmida. Sementes de P. reticulata não sobreviveram após tratamento de 140 ºC, mas sementes de S. adstringens de savana seca suportaram tratamento de 170 ºC, independentemente de estarem escarificadas e/ou embebidas. Conclui-se que sementes de P. reticulata são menos tolerantes a choques térmicos que sementes de S. adstringens, que sementes secas são mais tolerantes a choques térmicos que sementes embebidas, e que sementes de savanas secas são mais tolerantes a choques térmicos que sementes de ambientes úmidos.


  • Next Generation Sequencing. a Key in Search of Locks?

    by A. Ferreira, A.S.D.A. Gomes, P.M. Hoff, F.P. Costa, D.F. Saragiotto, A. Katz, G.D.S. Fernandes, K.K. Machado, F.C. Azevedo, M.I.F.M. Braghiroli, et al.

    Aim: Cancer treatment has rapidly evolved in the last decades. Research is mainly directed towards the development of targeted treatments based on individual patient and tumor characteristics. A major recent focus has been the use of sequencing tests that focus on targetable gene alterations. Comprehensive cancer genomic testing using Next-Generation Sequencing (NGS) technology is a very fast and efficient tool which identifies a large number of alterations, some of which may prove to be an important aid in therapeutic decision-making. Many challenges exist in the transition of these technologies from research tool to clinical practice. We aimed to investigate the effectiveness of the current NGS technology as an aid in the oncologic treatment at our institution. Methods: We retrospectively evaluated a cohort of 75 cases of patients with solid tumors treated from Nov. 11 until Feb. 14, who had their tumors sent for a commercially available sequencing assay that utilizes clinical grade NGS. We analyzed all patients for the identification of targetable gene alterations, and whether this result led to a change in treatment and final outcome. Results: Sixty-six patients (88%) were eligible for our analysis (47% female). Sixty-two (94%) had an identifiable mutation, and 11 (17%) received treatment directed by the NGS result. Seven of these 11 patients (63%) had their tumor analyzed by specimens from metastatic sites. Only one patient had a significant tumor response, which was achieved after 2 months of directed treatment, with disease progression 4 months later. The median number of treatment lines prior to the NGS test was 3. Conclusions: Current technology already allows us to identify a large number of mutated genes in cancer specimens. However, most of those mutations are not yet drugable. Our results were somewhat disappointing, with less than 10% response among those few who could receive the directed therapy. However, it is important to note that ours was a heavily pretreated population, and that a significant number of the mutations identified might not be real drivers to the tumor growth. The results of our study suggest that the NGS test is still largely investigational, and that its use as a rescue tool for heavily pretreated patients remains questionable. Disclosure: All authors have declared no conflicts of interest.